1.Current Status,Strategies and Prospects of Traditional Chinese Medicine Diagnosis and Treatment for Irritable Bowel Syndrome
Yandong WEN ; Zhi YANG ; Shaogang HUANG ; Zhongyu LI ; Xiangxue MA ; Qing XU ; Liqing DU ; Bochao YUAN ; Yibing TIAN ; Wentong GE ; Xiaofan ZHAO ; Chang LIU ; Xudong TANG
Journal of Traditional Chinese Medicine 2026;67(4):404-409
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized primarily by abdominal pain and altered defecation habits. In recent years, traditional Chinese medicine (TCM) has made progress in multiple aspects of IBS research and treatment, including syndrome distribution, development of TCM formulas, clinical efficacy evaluation, external therapies, and psychosocial regulation. However, it still faces challenges such as over-reliance on symptomatic manifestations rather than biomarkers for diagnostic criteria, and the lack of high-quality evidence-based data supporting the efficacy of TCM formulas in treating IBS. This paper proposed that TCM diagnosis and treatment of IBS should adhere to the strategy of integrating the holistic concept with syndrome differentiation and treatment, combining TCM external therapies such as acupuncture, moxibustion and acupoint application), and emphasizing individualized diagnosis and treatment for psychosomatic abnormalities. Future research should integrate multi-omics technologies, artificial intelligence and other methods to deepen the understanding of the pathogenesis of IBS and the mechanisms of TCM formulas, so as to promote the standardization and internationalization of TCM in the diagnosis and treatment of IBS.
2.Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Shuxuan QIU ; Lin GUO ; Ruiying WANG ; Xudong MA ; Mingsan MIAO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(9):276-283
Hepatic fibrosis (HF) is an abnormal repair process that occurs after chronic liver injury. It is characterized by excessive accumulation of extracellular matrix in the liver, resulting in fibrous tissue hyperplasia, which may further develop into cirrhosis and even liver cancer. Currently, there is a lack of specific anti-HF drugs in clinical practice. Traditional Chinese medicine (TCM) has advantages in the treatment of HF, including multi-component and multi-target interventions with high safety, and can significantly delay the progression of HF. It has therefore become a current research hotspot. Nuclear factor erythroid 2-related factor 2 (Nrf2), as a key transcription factor involved in antioxidant stress, can effectively intervene in the progression of HF by activating the expression of downstream antioxidant enzymes and detoxification genes. This article systematically reviews the mechanisms by which active components of Chinese medicine (such as flavonoids, polysaccharides, and saponins) and TCM compound prescriptions (such as Haobie Yangyin Ruanjian prescription and Biejia Xiaozheng pills) exert anti-fibrotic effects through activation of the Nrf2 signaling pathway, including enhancing antioxidant capacity, inhibiting inflammatory responses, reducing hepatocyte apoptosis, improving mitochondrial function, and inhibiting the ferroptosis pathway. In addition, this article points out the current shortcomings in research based on the Nrf2 signaling pathway and proposes corresponding suggestions to promote related studies. It also provides an important theoretical basis for the development of novel anti-HF Chinese medicine targeting Nrf2.
3.Clinical application of transperineal four-hole prostate puncture
Xudong JIA ; Haoxuan YANG ; Xin WANG ; Lei DU ; Ziyue MA ; Yan HE ; Mingxuan YANG ; Jinchun QI
Journal of Modern Urology 2026;31(3):268-271
Objective To compare the efficacy and safety of the transperineal four-hole prostate puncture with conventional transperineal prostate puncture. Methods A total of 91 patients undergoing transperineal prostate puncture at the Second Hospital of Hebei Medical University during Jan. 2024 and Jan. 2025 were enrolled. Based on the puncture methods, the patients were divided into the four-hole group(n=46)and conventional group(n=45). The four-hole group underwent four-hole puncture, while the conventional group received standardized parallel needle insertion. The operation time, intraoperative blood loss, pain score, positive biopsy rate, and complications were compared between the two groups. Results The intraoperative blood loss [(7.05±2.48)mL vs.(9.15±3.49)mL] and pain score [(2.33±1.55)vs.(3.02± 1.54)] of the four-hole group were significantly lower than those of the conventional group(P<0.05). No significant differences were observed in the positive biopsy rate [47.8%(22/46)vs. 46.7%(21/45)] or operation time [(18.83±2.49)min vs.(18.07±1.66)min](P>0.05). The total complication rate in the four-hole group was significantly lower than that in the conventional group [21.7%(10/46)vs. 42.2%(19/45), P<0.05]. Conclusion Compared with the conventional parallel needle insertion method, the four-hole puncture technique reduces the intraoperative blood loss, alleviates trauma severity and pain response, and reduces the complication rate.
4.Application of nanovesicle delivery systems in treatment of liver cancer
Hui MA ; Yanhua MA ; Chunxia MA ; Xudong TIAN
Journal of Clinical Hepatology 2026;42(6):1447-1453
Liver cancer is one of the most prevalent malignant tumors worldwide. Conventional radiotherapy and chemotherapy are often limited by poor targeting efficiency and significant adverse effects. Nanovesicle delivery systems have emerged as a research hotspot due to their superior biocompatibility and targeting potential. This article introduces the fundamental characteristics and main types of nanovesicles, elaborates on their mechanisms in targeting the liver, deeply analyzes their application potential in the treatment of liver cancer and related research advances, and discusses future challenges and development trends, in order to provide a reference for further research and clinical application of nanovesicles in targeted therapy for liver cancer.
5.Exploring Mechanism of Action of Tuoli Xiaodu San in Treating Ulcerative Colitis Based on Integrated Pharmacology and Transcriptomics
Longke MA ; Linzhen LI ; Haimei YANG ; Juan WANG ; Xudong WEN ; Yihan MA ; Xiaoxiang WANG ; Fating LU ; Qiaobo YE
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(14):205-215
ObjectiveTo investigate the material basis and mechanism of action of Tuoli Xiaodu San in treating ulcerative colitis (UC) by integrating transcriptomics, network pharmacology, and experimental validation. MethodsNetwork pharmacology was initially employed to screen the active components and potential mechanisms of Tuoli Xiaodu San for treating UC. A UC mouse model was established by dextran sulfate sodium (DSS) induction. The mice were divided into the following groups: normal, model, high-dose (11.3 g·kg-1) Tuoli Xiaodu San, low-dose (5.7 g·kg-1) Tuoli Xiaodu San, and positive control (mesalazine, 0.4 g·kg-1). Intragastric administration commenced on day 1 of modeling and continued for 7 consecutive days. The disease activity index (DAI) was assessed daily. Hematoxylin-eosin (HE) staining was used to observe colonic pathological changes. Serum levels of tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA). Transcriptome sequencing was performed on mouse colonic tissues, and the results were integrated with network pharmacology findings for in-depth analysis of Tuoli Xiaodu San's potential mechanisms in treating UC. Finally, the expression of key genes and proteins in the identified signaling pathways were detected using Western blot and Real-time polymerase chain reaction (Real-time PCR). ResultsThe combined analysis of network pharmacology and transcriptomics results showed that the multi-pathway network with phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway as its core was the key mechanism of Tuoli Xiaodu San in the treatment of UC. Tuoli Xiaodu San administration significantly ameliorated weight loss, diarrhea, and bloody stools in UC mice, reduced the DAI scores (P<0.05, P<0.01), lowered the colonic histopathological scores (P<0.01), alleviated colon shortening (P<0.01), and downregulated serum levels of TNF-α, IL-1β, and IL-6 (P<0.05, P<0.01). Molecular biology experiments confirmed that Tuoli Xiaodu San significantly inhibited the mRNA and protein expression, as well as the phosphorylation levels, of PI3K, Akt, and p65 in colonic tissues (P<0.05, P<0.01). ConclusionTuoli Xiaodu San can regulate the multi-pathway network with PI3K/Akt as its core through multi-component synergy, thereby reducing colonic inflammatory damage and exerting a therapeutic effect on UC.
6.Elevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis
Yuqian ZHENG ; Shaolong ZHOU ; Yiran TAO ; Zimin SHI ; Xiang LI ; Xudong FU ; Jian MA ; Weihua HU ; Wulong LIANG ; Xinjun WANG
Cancer Research and Treatment 2026;58(1):71-94
Purpose:
The aim of this study is to determine the impact of solute carrier family 3 member 2 (SLC3A2) on the malignant phenotype of gliomas and its role in regulating ferroptosis sensitivity.
Materials and Methods:
The malignant phenotype of glioma was assessed by cell proliferation assay, colony formation assay, EdU assay, wound healing, and Transwell experiments. We further validated the impact of reduced SLC3A2 expression on the sensitivity to ferroptosis in glioma cells through Cell Counting Kit-8 assays, flow cytometry, western blotting, and transmission electron microscopy. Western blot was used to explore how SLC3A2 affects glioma sensitivity to ferroptosis through the AKT/NF-E2-related factor 2 (NRF2)/glutathione peroxidase 4 (GPX4) axis. By establishing a subcutaneous xenograft tumor model in BALB/c-nude mice, we investigated the growth of tumors following the knockout of SLC3A2 in glioma cells.
Results:
Downregulation of SLC3A2 suppressed the malignant phenotype of glioma by blocking the cell cycle and epithelial-mesenchymal transition processes. On the other hand, loss of SLC3A2 not only downregulated SLC7A11 but also prevented the activation of the AKT/NRF2/GPX4 axis. These lead to increased accumulation of reactive oxygen species and lipid peroxides, ultimately enhancing the susceptibility of glioma to ferroptosis.
Conclusion
Our findings suggest that SLC3A2 is an oncogene in gliomas, promoting their occurrence and development. It plays a critical role in ferroptosis resistance through the AKT/NRF2/GPX4 axis.
7.Analysis on Distribution Characteristics and Influencing Factors of Potential Suitable Areas for Saussurea medusa Based on MaxEnt Model and Geographic Detector
Shaoyang XI ; Xudong GUO ; Xiaohui MA ; Li LIU ; Ling JIN
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(8):1-6
Objective To analyze the spatial distribution patterns and influencing factors of potential suitable habitats for Saussurea medusa under current climatic conditions.Methods The maximum entropy(MaxEnt)model with 125 selected distribution spots data and 9 environmental factors data of Saussurea medusa as input variables for modeling.Quantitative analysis was conducted on the influencing factors of spatial differentiation in the suitable habitat area of Saussurea medusa using geographic detector factor detection and interaction detection tools.Based on land use type data and national nature reserve distribution data,the distribution range of each land use type in the suitable habitat areas for Saussurea medusa,as well as the distribution pattern of high,medium and low suitable habitat areas in national nature reserves were refined.Results Key environmental determinants included elevation,precipitation in the warmest quarter,and solar radiation in April and May.The total potential suitable habitat area spanned 1.33×106 km2,accounting for 13.89%of China's mainland.Grasslands(67.70%),forests(19.19%),barren land(5.90%),snow-covered areas(2.59%)and croplands(2.08%)dominated the suitable habitats,with 34.98%overlapping national nature reserves.Conclusion The results of this study can provide basis for understanding the ecological needs and resource conservation of Saussurea medusa.
8.Expert consensus on non-surgical treatment for acute lateral ankle sprain (version 2025)
Hui CHE ; Wenge DING ; Shiming FENG ; Xueping GU ; Qinwei GUO ; Jianchao GUI ; Yinghui HUA ; Yuefeng HAO ; Qinglin HAN ; Bo HU ; Xiaojun LIANG ; Guoping LI ; Yunxia LI ; Qi LI ; Yanlin LI ; Xin MA ; Jun MA ; Xudong MIAO ; Jianzhong QIN ; Xiaodong QIN ; Xu SUN ; Kefu SUN ; Weidong SONG ; Dai SHI ; Zhongmin SHI ; Youlun TAO ; Xu WANG ; Youhua WANG ; Liheng WANG ; Anli WANG ; Aiguo WANG ; Weidong WU ; Yajun XU ; Weidong XU ; Renjie XU ; Yongsheng XU ; Tengbo YU ; Lianqi YAN ; Xiaodong YUAN ; Yuan ZHU ; Mingzhu ZHANG ; Hongtao ZHANG ; Xintao ZHANG ; Xiaofei ZHENG
Chinese Journal of Trauma 2025;41(6):517-529
Acute lateral ankle sprain (ALAS) is one of the most common sport injuries, with high incidence, recurrence and disability rates. Currently, exercise rehabilitation-based non-surgical treatment is the primary management approach for ALAS. However, there remain improper practices such as excessive immobilization or uncontrolled activity, which contribute to recurrent sprains and chronic ankle instability, significantly impairing patients′ athletic function and quality of life. To standardize the non-surgical management of ALAS, improve the cure rates, and reduce the recurrence and disability rates, Chinese Sports Rehabilitation Medicine Training Project of Chinese Medical Association, Foot and Ankle Basics and Orthopedics Group, Orthopedic Branch of Chinese Medical Doctor Association, and Sports Medicine Branch of Jiangsu Medical Association organized relevant experts to formulate Expert consensus on non-surgical treatment for acute lateral ankle sprain ( version 2025), following the principles of scientific vigor, practicality, and innovation. Thirteen recommendations were proposed for standardized treatment protocols across different healing phases, aiming to provide references for standard management of ALAS and improve the therapeutic outcomes.
9.Efficacy of selinexor combined with subcutaneous decitabine in myeloid malignancies refractory to or relapsed after venetoclax therapy
Ruihua MI ; Lin WANG ; Ning HU ; Chao LI ; Lin CHEN ; Yixuan MA ; Xudong WEI
Chinese Journal of Hematology 2025;46(5):473-477
Venetoclax (Ven) is now widely used for both acute myeloid leukaemia (AML) and high-risk myelodysplastic syndrome (MDS), yet there is no consensus on salvage regimens after Ven failure. This study retrospectively evaluated the efficacy and safety of selinexor combined with subcutaneous decitabine (DAC) in 10 patients with AML or MDS with excess blasts (MDS-EB1/2) who had experienced prior Ven treatment failure. A literature review was also performed. Among the 7 patients with AML, 1 achieved complete remission (CR), 2 achieved CR with incomplete hematologic recovery (CRi), 1 achieved partial remission (PR), 2 had no remission, and 1 experienced disease progression (PD). Among the 3 patients with MDS, 2 achieved marrow CR and 1 had stable disease (SD). The median duration of response among the 6 responding patients was 2 months (range, 0.5-6 months). All 10 patients experienced varying degrees of myelosuppression. Five patients had mild gastrointestinal reactions, all of which were manageable. The overall tolerability was good, and no treatment-related deaths occurred. These findings suggest that selinexor combined with subcutaneous decitabine offers a novel and well-tolerated therapeutic option for patients with myeloid malignancies who have previously failed venetoclax-based therapy.
10.The effect of dynamic instability training on the balance and posture control of persons with chronic ankle instability
Lianjie MA ; Jianming FU ; Yan LI ; Xudong GU ; Ming ZENG ; Xinxin SONG ; Yuhong SHU
Chinese Journal of Physical Medicine and Rehabilitation 2025;47(8):715-720
Objective:To observe any effect of dynamic instability training on the balance and posture control of persons with chronic ankle instability (CAI).Methods:Thirty persons with CAI were divided at random into a control group and an observation group, each of 15. Both groups received routine rehabilitation interventions (including ankle strength training, kinesio taping, and vibration training), while the observation group additionally underwent 20 minutes of dynamic instability training daily, 5 days a week for 4 consecutive weeks. Before and after the treatment, everyone′s balance was evaluated using the Berg balance scale (BBS) and the star moving balance test (SEBT). Surface electromyography (sEMG) was used to collect electromyograms of the affected peroneus longus, tibialis anterior, rectus femoris and medialis femoris muscles of both groups within 100ms before and after landing in the jump-landing test. The intensity of muscle activation was thus analyzed.Results:After the treatment there was significant improvement in the average BBS scores, anterior medial SEBT, medial SEBT and posterior medial SEBT results of both groups. On average, all three SEBT results [(80.27±4.06)cm, (90.27±4.06)cm and (97.73±3.47)cm respectively] were significantly better in the observation group than in the control group. The standardized integrated electromyographs of the peroneus longus, tibialis anterior, rectus femoris and medialis femoris muscles on the affected sides showed significant improvement compared with before the treatment, but there too the observation group′s results were significantly better than those of the control group.Conclusions:Combining dynamic instability training with conventional rehabilitation can further improve the balance and postural control of persons with chronic ankle instability.

Result Analysis
Print
Save
E-mail